E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPAMIC0110(Antimicrobial peptide)
DFBP ID DFBPAMIC0110
Peptide sequence FFHHIFRGIVHVGKTIHRLVTG
Type Native peptide
Peptide/Function name Antimicrobial peptide, Piscidin 1
Function-activity relationship
Main bioactivity Antimicrobial activity
Otheir bioactivity Anticancer activity [D1]
Calculated physicochemical properties
Three-letter amino acid Phe-Phe-His-His-Ile-Phe-Arg-Gly-Ile-Val-His-Val-Gly-Lys-Thr-Ile-His-Arg-Leu-Val-Thr-Gly
Single-letter amino acid FFHHIFRGIVHVGKTIHRLVTG
Peptide length 22
Peptide mass
Experimental mass Theoretical mass
N.D 2572.06 Da c
Net charge +3
Isoelectric point (pI) 12.52 c
IC50 N.D
pIC50 N.D
GRAVY 0.4545 c
Hydrophilic residue ratio 59.09% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Hybrid striped bass (Morone saxatilis x Morone chrysops)
Precursor protein Mast cells, gill, skin, intestine, spleen and anterior kidney
Residue position N.D
Precursor protein(s) search
No matching precursor protein found
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Antimicrobial activity

(1) anti-Gram+ & Gram-, antiviral,  antifungal,  anti-HIV,  Mammalian cells,  Cancer cells;
(2) First AMP isolated from mast cells. Active against E. coli, P. aeruginosa, S. typhimurium, B. subtilis, and S. aureus (MIC 1-4 uM) [1], including MRSA USA300 (MIC 3.1 uM) [2].  It is also active against channel catfish virus (CCV), frog virus 3 (FV3) [3] as well as HIV-1 (EC50 = 1.4 uM) [4].

Table 1 Antibacterial activity of piscidins.
Bacteria
Minimum inhibitory concentration
Minimum bactericidal concentration
Piscidin 1
Piscidin 3
Piscidin 1
Piscidin 3
Fish pathogens
Streptococcus iniae (+)
3.1
3.1
3.1
3.1
Lactococcus garviae* (+)
3.1
6.3
3.1
12.5
L.garviaet (+)
3.1
3.1
3.1
6.3
Aeromonas salmonicida (-)
3.1
12.5
3.1
25.0
Aeromonas hydrophila (-)
0.8
1.6
0.8
1.6
Vibrio aiginolyticus (-)
3.1
6.3
3.1
6.3
Human pathogens
Staphylococcus aureus (+)
3.1
3.1
3.1
3.1
Streptococcus faecalis (+)
3.1
12.5
3.1
12.5
Escherichia coli (-)
3.1
3.1
3.1
3.1
Klebsiella pneumoniae (-)
3.1
6.3
3.1
6.3
Shigella flexneri (-)
3.1
6.3
3.1
6.3
Pseudomonas aeruginosa (-)
12.5
25.0
12.5
25.0
Specific target protein(s) N.D
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools No prediction can be made about the peptide bitterness. prediction
SMILES N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(Cc1ccccc1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)NCC(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(C(C)C)C(=O)NCC(=O)N[C@@]([H])(CCCCN)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)N[C@@]([H])([C@]([H])(CC)C)C(=O)N[C@@]([H])(CC1=CN=C-N1)C(=O)N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(CC(C)C)C(=O)N[C@@]([H])(C(C)C)C(=O)N[C@@]([H])([C@]([H])(O)C)C(=O)NCC(=O)O
Preparation method
Mode of preparation Extract without enzyme
Enzyme(s)/starter culture No enzyme
Stability & Cytotoxicity
Peptide stability
Literature report: N.D
EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
DFBP
[D1] DFBPANCA0385
BIOPEP-UWM [D2] -
APD [D3] -
BioPepDB [D4] -
MBPDB [D5] -
Reference(s)
Primary literature Silphaduang U, Noga EJ. Peptide antibiotics in mast cells of fish. Nature. 2001 Nov 15;414(6861):268-9.
PMID: 11713517
Other literature(s) [1] Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of Piscidin 1.
[2] Menousek J, Mishra B, Hanke M L, et al. Database screening and in vivo efficacy of antimicrobial peptides against meticillin-resistant Staphylococcus aureus USA300[J]. International Journal of Antimicrobial Agents, 2012, 39(5):402-6.
[3] Chinchar V G, Bryan L, Silphadaung U, et al. Inactivation of viruses infecting ectothermic animals by amphibian and piscine antimicrobial peptides[J]. Virology, 2004, 323(2):268-75.
[4] Wang G, Watson K M, Peterkofsky A, et al. Identification of Novel Human Immunodeficiency Virus Type 1-Inhibitory Peptides Based on the Antimicrobial Peptide Database[J]. Antimicrobial Agents & Chemotherapy, 2010, 54(3):1343-6.
PubDate 2001
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214